Simplex Trading
AXSM icon

Simplex Trading’s Axsome Therapeutics AXSM Stock Holding History

Simplex Trading’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.01M Sell
12,300
-5,600
-31% -$1.21M ﹤0.01% 1622
2026
Q1 		$3.03M Buy
17,900
+2,500
+16% +$432K ﹤0.01% 1494
2025
Q4 		$2.81M Sell
15,400
-39,900
-72% -$5.57M ﹤0.01% 1708
2025
Q3 		$6.72M Buy
55,300
+6,000
+12% +$676K ﹤0.01% 1224
2025
Q2 		$5.15M Sell
49,300
-11,900
-19% -$1.26M ﹤0.01% 1322
2025
Q1 		$7.14M Sell
61,200
-104,400
-63% -$11.9M ﹤0.01% 1085
2024
Q4 		$14M Buy
165,600
+115,300
+229% +$10.6M 0.01% 829
2024
Q3 		$4.52M Buy
50,300
+4,000
+9% +$349K ﹤0.01% 1566
2024
Q2 		$3.73M Sell
46,300
-16,100
-26% -$1.19M ﹤0.01% 1643
2024
Q1 		$4.98M Buy
62,400
+25,200
+68% +$2.12M ﹤0.01% 1608
2023
Q4 		$2.96M Buy
37,200
+4,400
+13% +$294K ﹤0.01% 2020
2023
Q3 		$2.29M Sell
32,800
-36,200
-52% -$2.71M ﹤0.01% 1958
2023
Q2 		$4.96M Sell
69,000
-27,400
-28% -$2.02M ﹤0.01% 1325
2023
Q1 		$5.95M Sell
96,400
-88,700
-48% -$5.83M 0.01% 1188
2022
Q4 		$14.3M Buy
185,100
+86,900
+88% +$5.19M 0.02% 699
2022
Q3 		$4.38M Sell
98,200
-21,900
-18% -$1.09M 0.01% 1290
2022
Q2 		$4.6M Buy
120,100
+60,700
+102% +$1.92M ﹤0.01% 1200
2022
Q1 		$2.46M Sell
59,400
-7,800
-12% -$242K ﹤0.01% 1893
2021
Q4 		$2.54M Buy
67,200
+61,800
+1,144% +$2.27M ﹤0.01% 1787
2021
Q3 		$368K Hold
5,400
– – ﹤0.01% 4566
2021
Q2 		$364K Buy
5,400
+5,313
+6,107% +$319K ﹤0.01% 4649
2021
Q1 		$492K Buy
+87
New +$6.12K ﹤0.01% 3401
2020
Q2 		– Sell
-701
Closed -$4.12M – 7583
2020
Q1 		$4.12M Sell
701
-351
-33% -$28.6K 0.01% 802
2019
Q4 		$10.9M Buy
1,052
+885
+530% +$35.7K 0.02% 436
2019
Q3 		$338K Sell
167
-205
-55% -$5.27K ﹤0.01% 3049
2019
Q2 		$957K Sell
372
-508
-58% -$10.2K ﹤0.01% 1943
2019
Q1 		$1.25M Buy
+880
New +$8.17K ﹤0.01% 1799

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Simplex Trading's AXSM Position: Q2 2026 in Review

Simplex Trading opened a new position in Axsome Therapeutics (AXSM) in Q2 2026: 19,643 shares worth $4.81M. The stake represents ﹤0.01% of the portfolio and ranks #1239 among its holdings. This is a return to the name: Simplex Trading previously reported a position in AXSM as recently as Q4 2025.

Simplex Trading first reported a position in AXSM in Q3 2018 and has held it in 29 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Simplex Trading held 19,643 shares of Axsome Therapeutics worth $4.81M as of Q2 2026.
  • Axsome Therapeutics was a new Simplex Trading position in Q2 2026.
  • Axsome Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #1239 holding.
  • Simplex Trading first reported a position in Axsome Therapeutics in Q3 2018 and has held it in 29 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.